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Abstract
Background: Thyroid cancer incidence rates have been increasing worldwide but the reason behind this is unclear. Both the
increasing use of diagnostic technologies allowing the detection of thyroid cancer and a true increase in thyroid cancer
incidence have been proposed. This review assesses the role of body mass index (BMI), diet, and reproductive factors on the
thyroid cancer trend.
Methods: Epidemiologic studies of the selected risk factors up to June 2010 were reviewed and critically assessed.
Results: Among the thirty-seven studies reviewed and despite variation in the risk estimates, most papers supported a small
but positive association for BMI (risk estimate range: 1.1–2.3 in males and 1.0–7.4 in females.). Among specific dietary
components, there was no consistent association of thyroid cancer risk with iodine intake through fortification (risk estimate
range: 0.49–1.6) or fish consumption (risk estimate range 0.6–2.2), nor with diets high in cruciferous vegetables (risk
estimate range 0.6–1.9). A small number of studies showed a consistent protective effect of diets high in non-cruciferous
vegetable (risk estimate range: 0.71–0.92). Among reproductive factors (pregnancy, parity, number of live births, use of
prescription hormones, menstrual cycle regularity, and menopausal status), none were consistently associated with higher
thyroid cancer risk.
Conclusions: BMI had the strongest link to thyroid cancer risk among those examined. Detailed examinations of population-
level risk factors can help identify and support prevention efforts to reduce the burden of thyroid cancer.
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Introduction
Over the past 30 years many countries have experienced a
dramatic rise in the incidence of thyroid cancer, with a study
across five continents showing the average increase to be 67% in
females and 48% in males between 1973 and 2002 [1]. While the
increase in thyroid cancer incidence has been almost universal, it
has varied across countries in magnitude [1], as well as by ethnic
[2] and other population subgroups [3].
The increase in thyroid cancer incidence is mainly associated
with papillary carcinoma, with smaller increases occurring in other
types such as follicular carcinoma [3,4,5]. While the increase
includes both sexes and all age groups, the most rapid increase has
occurred among women of reproductive age [6,7]. The incidence
of thyroid cancer is higher in women than men with a consistent
ratio of 3:1, except for in the adolescent and young adult age
group where the incidence in females is as much as 5-fold higher
[8]. Furthermore, some research shows an increase in predomi-
nantly small tumors [9,10,11] while other studies indicate
increases across all tumor sizes [1,2,12].
Ionizing radiation is the best established risk factor for thyroid
cancer based on studies of atomic fallout, nuclear accidents, and
radiation treatment for benign conditions or previous cancers
[13]. While these exposures affect specific groups of people, the
population-level risk factors that could account for the
widespread increase in thyroid cancer incidence have not yet
been identified. One possible explanation for the upward trend is
the increasing use of diagnostic technologies allowing the
detection of thyroid cancer [10,11,14,15]. Other authors posit
a true increase in thyroid cancer incidence due to a widespread
increase in a yet unidentified environmental or lifestyle factor(s)
[2,12,16,17,18]
Throughout the world, changes in diet, physical activity and
average body weight have tended to occur as countries become
more developed, with these changes accounting for as much as
30% of all cancers [19]. This paper critically reviews the
literature on the major lifestyle-related risk factors that are most
strongly suspected of affecting thyroid cancer rates – body mass
index (BMI), diet (including iodine intake), and fish and
vegetable consumption. This paper also reviews the major
reproductive factors that could account for the higher rates of
thyroid cancer among women – pregnancy history, menstrual
cycle regularity, menopausal status and the use of prescription
hormones.
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Search strategy
Although the current paper reviews the evidence on lifestyle and
behavioral risk factors, the search strategy was broadly designed to
identify all risk factors – lifestyle, behavioral or environmental – for
thyroid cancer. The environmental risk factors (diagnostic
radiation and endocrine disrupting chemicals) are reviewed in a
separate paper (Peterson et al., submitted).
A search for peer-reviewed epidemiological articles was
performed using MEDLINE and EMBASE for all articles
published between January 1980 and June 2010. The keywords
and MeSH terms used for the search were ‘thyroid cancer’
(‘thyroid neoplasm’ for MEDLINE) AND ‘incidence’ OR ‘risk
factors’ OR ‘cosmic radiation’ OR ‘electromagnetic radiation’
(‘background radiation’ for MEDLINE) OR ‘ionizing radiation’
OR ‘radiation’ OR ‘radiation dose’(‘radiation effects for MED-
LINE) OR ‘radiation exposure’ OR ‘reproduction’ OR ‘estro-
gen’(EMBASE only) OR ‘hormone’ (EMBASE only) OR
‘parity’(MEDLINE only) OR ‘pregnancy’ (MEDLINE only) OR
‘reproductive history’ (MEDLINE only) OR ‘oral contraceptive
agent’ OR ‘iodine’ OR ‘iodine deficiency’ OR ‘diet’ OR ‘body
mass’ OR ‘diagnostic test’ (‘diagnostic equipment‘ OR ‘diagnostic
techniques’ for MEDLINE) OR ‘endocrine disruptors’ OR
‘pesticides’ OR ‘environmental pollutants’. In addition to this
search, other papers were found by manually examining the
reference lists of retrieved articles. A search for grey literature was
performed using Google Scholar and thyroid-related websites (e.g.
professional medical associations and thyroid cancer charities).
Inclusion and exclusion criteria
In this review, we included English or French language studies
that focused on the association of thyroid cancer with each of the
following: BMI, female reproductive factors (pregnancy, synthetic
hormones, and menstrual factors) and diet, which included iodine
intake through fortification or fish consumption. No restrictions
were placed on age, sex, geographic region of study and study
design. However, studies were required to provide measures of
association to be included in the review. If previous pooled studies
or meta-analyses were available, we excluded the individual
studies of the pooled analysis from our review and examined the
pooled results only.
Studies of unique subpopulations were excluded because they
are not representative of the general population. These included
studies where exposure was from occupation, radioactive iodine-
131, treatment for benign thyroid conditions (nodules, goiter,
thyroiditis), or the existence of familial or genetic risk factors
(MEN2A and MEN2B syndromes; familial adenomatous polyposis
(FAP)).
Review and analysis
Abstracts of papers were reviewed by two authors (EP and PD)
to determine their relevance to the inclusion criteria. Any
discrepancies between the two reviewers were resolved through
discussion and consensus. For abstracts selected for further review,
the full papers were retrieved and further reviewed by all authors
against the inclusion criteria. The final selection of papers were
critiqued using the STROBE checklist (STROBE statement:
strengthening the reporting of observational studies in epidemiol-
ogy, Version 4) as a guide to critically assess studies for selection
and measurement bias, confounding, sample size, statistical
procedures and generalizability.
Measures of risk (odds ratios, relative risks ratios, hazard ratios)
were abstracted from the studies and used to create forest plots. A
meta-analysis of the data was not performed due to the
heterogeneity of the methods and risk factor definitions across
studies. Notable variations in study populations or risk character-
istics were, however, indicated on the plots.
Results
From an initial list of 6677 potentially relevant studies, 37
studies on BMI, diet and reproductive history were retained for
review. No articles were retrieved through the gray literature
search. The selection process for the articles is shown in Figure 1
and a range of the risk estimates found for each risk factor is
presented in Table 1.
Body mass index
We identified 22 studies on BMI that met the inclusion criteria,
5 of which were part of a meta-analysis and 9 were part of a
pooled-analysis, which we reviewed. Thus, the 8 studies retained
included one meta-analysis, one pooled analysis, three prospective
cohort studies and three case-control studies. Summaries of these
studies and an assessment of their strengths and weaknesses are
presented in Table S1. Most of these studies supported a positive
association of BMI with thyroid cancer, with risk estimates ranging
from 1.1 to 2.3 in males and 1.0 to 7.4 in females (Figure 2).
A meta-analysis of studies from Europe, Australia and Asia-
Pacific looked at the association between BMI and all types of
cancer and included five studies that examined thyroid cancer
[20]. This analysis showed an increased risk of thyroid cancer in
men (RR 1.33, 95%CI 1.04–1.70) and women (RR 1.14, 95%CI
1.06–1.23) for every 5 kg/m
2 increase in BMI. This meta-analysis
included only prospective studies, which establishes a temporal
relationship between body mass index and thyroid cancer.
A pooled analysis of twelve case-control studies from the United
States, Japan, China and Europe examined BMI and thyroid
cancer among 2473 cases and 4323 controls [21]. BMI at the time
of diagnosis showed a marginal association with thyroid cancer in
females (OR 1.2, 95%CI 1.0–1.4) and no association in males (OR
1.0, 95%CI 0.8–1.4). Since BMI was measured at the time of
thyroid cancer diagnosis, a temporal relation between the
exposure and outcome could not be determined.
There have been three additional prospective cohort studies on
BMI and thyroid cancer published since the meta-analysis. One
study on women between the ages of 40 and 65 in France found
that for every 5 kg/m
2 unit increase in BMI there was a 20%
elevated risk of thyroid cancer (HR 1.20, 95%CI 1.04–1.38) [22].
A second study of men and women aged 50–71 in the United
States found that people who were overweight (BMI=25–29.9) or
obese (BMI$30) at baseline were at an increased risk of thyroid
cancer, with relative risks of 1.27 (95%CI 0.99–1.64) and 1.47
(95%CI 1.03–2.10) respectively [23]. When the analysis of those
with a BMI$30 was stratified by sex, a positive association was
observed in males (RR 1.89, 95%CI 1.21–2.96) but not in females
(RR 1.10, 95%CI 0.75–1.61). A third study from the United States
found that a BMI .35 kg/m
2 was associated with an increased
risk of thyroid cancer in women (HR 1.74, 95%CI 1.03–2.94) but
not in men (HR 2.14, 95%CI 0.6–7.67) [24]. Because these three
studies were prospective in nature a temporal relationship between
thyroid cancer and BMI could be established.
There have also been three additional case-control studies on
BMI and thyroid cancer published since the pooled analysis. One
study of New Caledonia women found an association between
thyroid cancer and a BMI of 30–34.99 (OR 1.92, 95%CI 1.14–
3.22) and .35 (OR 1.85, 95%CI 1.02–3.35) [25]. When these
measures were stratified by age, women with a BMI of 30–34.99
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95%CI 1.43–14.54) but not if they were younger than 50 (OR
1.95, 95%CI 0.74–5.17). There was no association between
BMI and thyroid cancer found among men in this study. A
second case-control study from Japan found that patients with a
current BMI of 24–31 were associated with a higher risk of
thyroid cancer (OR 1.71, 95%CI 1.06–2.78) when compared to
those with a BMI between 16 and 21 [26]. When examined by
sex, the risk estimates showed males (OR 4.21, 95%CI 1.13–
15.70) being at higher risk than females (OR 1.48, 95%CI 0.86–
2.57). A third study in French Polynesia found an increased risk
for thyroid cancer in women within the highest quartile of BMI
at diagnosis when compared to the lowest (OR 2.3, 95%CI 1.2–
4.4) [27]. In males, thyroid cancer risk was increased in those
with a BMI at diagnosis above the median compared to those
below (OR 7.4, 95%CI 1.3–42.3). Increased BMI at age 18, 30
and 40 was also associated with an increased risk of thyroid
cancer in this study.
Diet
We identified 21 studies on diet (including iodine intake) and
thyroid cancer. Nine were excluded because they were the basis of
two pooled analyses, which are included in our analysis. Of the 12
studies retained, most showed a protective (inverse) effect
(although generally not statistically significant) with only one
showing a positive association of food consumption with thyroid
Table 1. Range of risk estimates for thyroid cancer for
selected risk factors.
Risk factor Risk estimate range
Body mass index
Males 1.1–2.3
Females 1.0–7.4
Diet and iodine intake
Iodine supplementation 0.49–1.6
Fish consumption 0.6–2.2
Cruciferous vegetables 0.6–1.9
Non-cruciferous vegetables 0.71–0.92
Reproductive factors
Ever pregnant 0.56–1.1
Ever parous 0.73–1.7
Use of oral contraceptives 0.6–2.46
Use of estrogen 0.6–2.94
se of hormone replacement therapy 0.2–1.2
Irregular menstrual cycle 1.0–1.9
doi:10.1371/journal.pone.0029177.t001
Figure 1. Study selection process. This flowchart includes the study identification process for this paper and studies on environmental risk factors
for thyroid cancer that were reviewed in a separate paper.
doi:10.1371/journal.pone.0029177.g001
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strengths and weaknesses are presented in Table S2. Risk estimates
ranged from 0.49 to 2.2 for various types of dietary exposures
(Figures 3 and 4). These studies were inconsistent in the food types
that were investigated, which made it difficult to compare results
across studies. However, three main categories of food exposures
emerged – iodine food fortification, fish consumption and
vegetable consumption.
Iodine food fortification. The relationship between iodine
intake and thyroid cancer is unclear. Research suggests that
chronic iodine deficiency is associated with an increased risk of
follicular carcinomas, whereas high iodine intake is associated with
increased papillary carcinoma [28]. A search for epidemiological
studies on iodine intake and thyroid cancer found five studies that
met the inclusion criteria; two case-control studies and three
ecological studies. The relative risk estimates from these studies
ranged from 0.49 to 1.6.
A case-control study in Hawaii included female and male
residents above the age of 18 and examined the association
between dietary iodine intake and thyroid cancer in 191 cases and
442 controls [29]. When the highest iodine intake quartile was
compared to the lowest, a non-significant increased risk for thyroid
cancer was found among women (OR 1.6, 95%CI 0.8–3.2) and
men (OR 1.3, 95%CI 0.4–3.7).
A second case-control study of 608 women with thyroid cancer
and 558 controls between the ages of 20 and 70 in the San
Francisco Bay Area examined dietary iodine intake and iodine
levels measured in toenail clippings [30]. A significant reduction in
the risk of papillary thyroid cancer was seen in the highest iodine
intake quintile compared to the lowest (OR 0.49, 95%CI 0.29–
0.84); there was no association between dietary iodine and
follicular carcinomas. However, significantly lower nail iodine
levels were found in cases with follicular cancer than in controls
(p=0.02) but not with papillary cancer.
Figure 2. Forest plot of risk estimates for BMI and thyroid cancer for all pathologies of thyroid cancer and all age groups. A meta-
analysis of the data was not performed due to the heterogeneity of the methods and risk factor definitions across studies. Notable differences in
study characteristics and study samples are indicated on the plot.
doi:10.1371/journal.pone.0029177.g002
Lifestyle and Behavioural Risks for Thyroid Cancer
PLoS ONE | www.plosone.org 4 January 2012 | Volume 7 | Issue 1 | e29177Three ecological studies each showed an association between
iodine intake and papillary carcinoma incidence. One study from
Sweden found that the risk of developing papillary carcinoma is
lower in regions that are deficient in iodine compared to regions
with sufficient iodine (RR 0.80, 95%CI 0.73–0.88) [31].
However, over the study period the age-standardized incidence
rates of papillary thyroid cancer increased two-fold in both the
iodine deficient and iodine sufficient regions, suggesting that
increasing rates are not related to iodine supplementation. A
second study found that the age-specific incidence of papillary
thyroid cancer was higher in Iceland (a region with high iodine
intake) compared to northeast Scotland (a region with low iodine
intake), although no statistical analysis was done [32]. A third
study from Argentina found a significant increase (p,0.001) in
papillary carcinoma in the years after iodine was added to salt,
compared to the pre-prophylaxis period [33]. The results of these
ecological studies should be interpreted with caution since they
did not control for confounding from other known or suspected
thyroid cancer risk factors that may have changed over the time
period. In addition, the studies that examined two different
populations did not account for differences other than iodine
intake. Lastly, these studies were done at an ecological level and
associations may not necessarily be reflected at the individual
level.
Iodine through fish consumption. Fish and seafood are
one of the main sources of dietary iodine. We found four
epidemiological studies on fish consumption and its association
with thyroid cancer. One of these was a pooled analysis of case-
control studies published between 1980 and 1997 and three
were case-control studies published after 1997. The distribution
of risk estimates from these studies ranged from 0.6 to 2.2
(Figure 3).
A pooled analysis of thirteen case-control studies included 2497
cases and 4337 controls from the United States, Japan, China and
Europe. This study found no association of thyroid cancer among
people with the highest level of fish consumption compared to
those with the lowest level (OR 0.88, 95%CI 0.71–1.1) [34]. There
was a significant decrease in thyroid cancer risk with high fish
consumption in regions with endemic goiter (OR 0.65, 95%CI
0.48–0.88) but not in iodine rich regions (OR 1.1, 0.85–1.5). No
significant associations were found for saltwater fish consumption
or shellfish consumption and thyroid cancer.
There have since been three additional case control studies on
fish consumption and thyroid cancer. A study of women in the San
Figure 3. Forest plot of risk estimates for fish consumption and thyroid cancer for all types of fish, saltwater fish, shellfish, and
freshwater fish. The plot does not include other types of fish consumption discussed in the paper. A meta-analysis of the data was not performed
due to the heterogeneity of the methods and risk factor definitions across studies. Notable differences in study characteristics and study samples are
indicated on the plot.
doi:10.1371/journal.pone.0029177.g003
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thyroid cancer and any type of fish consumption – shellfish,
saltwater fish, freshwater fish or canned tuna [30]. A second study
from Kuwait found a protective effect with the consumption of
more than 2 servings of fresh fish per week (OR 0.5, 95%CI 0.4–
0.7) but an increased risk of thyroid cancer with the consumption
of processed, canned or frozen fish (OR 2.2, 95%CI 1.6–3.0)[35].
The authors suggested that the elevated risk associated with
processed fish may be related to higher iodine levels in processed
fish or to altered iodine uptake due to additives or processing. No
association with thyroid cancer was found with total fish
consumption or shellfish consumption. A third study of women
in Los Angeles County found no association between any amount
of fish consumption (shellfish, saltwater fish and freshwater fish)
consumption and thyroid cancer risk [36].
Vegetable consumption. Cruciferous vegetables (e.g.
cabbage, Brussel sprouts, broccoli, cauliflower, radish, turnip)
contain thioglucosides, which can induce thyroid cancer in
laboratory animals [37]. We reviewed four epidemiological
studies on cruciferous and non-cruciferous vegetable intake and
thyroid cancer. One was a pooled analysis of studies published
between 1980 and 1997 and three were case-control studies that
looked at multiple dietary risk factors, including vegetable intake.
Risk estimates for cruciferous vegetable consumption ranged from
0.6 to 1.9, and for non-cruciferous vegetables ranged from 0.71 to
0.92 (Figure 4).
A pooled analysis of 11 case-control studies from the United
States, Asia and Europe considered vegetable intake in 2241 cases
and 3716 controls [38]. This analysis found no significant
association of thyroid cancer among people who consumed the
highest amount of total cruciferous vegetables compared to those
with the lowest consumption levels (OR 0.94, 95%CI 0.80–1.10).
There was, however, a decrease in thyroid cancer risk among
those who consumed the highest amounts of non-cruciferous
vegetables compared to those with the lowest consumption levels
(OR 0.82, 95%CI 0.69–0.98).
There have since been three additional case-control studies
published after the pooled analysis. One from Kuwait found an
increased risk of thyroid cancer with the consumption of cabbage
(OR 1.9, 95%CI 1.1–3.3), a marginal increase in risk with the
consumption of cauliflower (OR 1.8, 95%CI 1.0–3.2), and no
association with the consumption of Brussels sprouts, broccoli or
green vegetables [35]. A second study of women in Los Angeles
found a decreased risk of thyroid cancer with the consumption of
cruciferous vegetables (turnips and rutabagas) (OR 0.6, 95%CI
0.3–1.0) [36]. A third study from Greece found a decreased risk
with the consumption of a select group of non-cruciferous raw
vegetables (OR 0.71, P=0.02) and raw tomatoes (0.92, 95%CI
0.85–0.99) [39].
Other dietary items: We reviewed three other case-control
studies that looked at the relationship between thyroid cancer and
food items or groups other than iodine, fish or vegetables. Because
Figure 4. Forest plot of risk estimates for thyroid cancer from consumption of cruciferous and non-cruciferous vegetables. A meta-
analysis of the data was not performed due to the heterogeneity of the methods and risk factor definitions across studies. Notable differences in
study characteristics and study samples are indicated on the plot.
doi:10.1371/journal.pone.0029177.g004
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patterns can be described. One study from northern Italy found an
increased risk of thyroid cancer with high refined cereal intake
(OR 2.0, 95%CI 1.4–2.9) and a marginal association with low
beta-carotene intake (OR 1.4, 95%CI 1.0–1.9) [40]. The authors
suggested that these measures are likely indicative of an overall
poor diet. A second study of women in the San Francisco Bay Area
found that increased consumption of total phytoestrogens (mainly
through soy consumption) was associated with a decreased risk of
thyroid cancer (OR 0.62, 95%CI 0.39–0.99) [41]. Phytoestrogens
are estrogenic compounds found in plant foods, such as soy, that
can bind with estrogen receptors. A third study from Greece
conducted a factor analysis of various combinations of food items
to determine their association with thyroid cancer [39]. A
combination of raw vegetables typically found in a Greek salad
decreased the risk of thyroid cancer. A decreased risk for thyroid
cancer was also found with the consumption of fruits (OR 0.68,
p=0.01) and mixed vegetables and fruits (OR 0.73, p=0.04). An
increased risk for follicular carcinoma was associated with the
consumption of a combination of fish and cooked vegetables (OR
2.79, p=0.02).
Reproductive factors
We identified 29 studies on reproductive factors that covered
the topics of pregnancy, menstrual cycle, menopause and use of
prescription hormones. Twelve studies were excluded because
they were part of pooled analyses, which are included in our
review. Thus, of the 17 studies we reviewed there were 2 pooled
analyses, 6 cohort studies and 9 case-control studies. These studies
are discussed in detail in the Text S1 and Table S3.
Among these studies, the common reproductive factors that
were assessed were: ever being pregnant, ever being parous,
number of pregnancies and live births, use of prescription
hormones (including oral contraceptives (OC), estrogen and
hormone replacement therapy), menstrual cycle regularity, and
menopausal status. Individual risk estimates showed wide variation
– pregnancy (0.56–1.1), number of live births (0.73–1.7), OC use
(0.6–2.46), estrogen use (0.6–2.94), HRT use (0.2–1.2), and
menstrual cycle irregularity (1.0–1.9) – and none of these risk
factors were consistently associated with a change in risk of thyroid
cancer (see Figures S1, S2, and S3).
Discussion
Numerous epidemiological studies have looked at risk factors for
thyroid cancer in order to explain the increasing rates of this
cancer throughout the world and specifically among women. In
this report, we critically reviewed the risk factors that are
associated with diet and nutrition and those related to a woman’s
reproductive history. No one factor was consistently associated
with a strong increase in thyroid cancer risk, although a higher
BMI did show mostly positive associations. The studies reviewed
here were performed in different countries but there was no clear
directionality in thyroid cancer risk with ethnicity of the study
population.
While some of the reviewed risk factors were the subject of a
recent review by Dal Maso and colleagues [42], our study
updates and expands on that review and highlights the limitations
of available research. The most common limitations across the
studies we reviewed were i) a lack of statistical adjustment for
other putative thyroid cancer risk factors, ii) small numbers of
thyroid cancer cases among study populations, which lowered
statistical power, iii) low accuracy or reliability of exposure
information due to self-reported data, iv) few prospective studies
to adequately assess temporality of exposure to a risk factor and
development of thyroid cancer and v) a lack of simultaneous
consideration of multiple risk factors in the assessment of thyroid
cancer risk.
Body mass index (BMI)
Several studies showed that a higher BMI is weakly associated
with an elevated risk of thyroid cancer. No clear trend was
observed between study population or thyroid tumor type and the
association between BMI and thyroid cancer. However, one study
did find a positive association of BMI with papillary, follicular and
anaplastic thyroid cancers but not with medullary thyroid cancer
[23]. Half of the studies reviewed here were prospective cohort
studies suggesting that a higher BMI preceded a diagnosis of
thyroid cancer.
Worldwide, obesity rates have been increasing over the last 30
years. In Canada, for example, the average BMI for a typical
forty-five year old male or female have increased by approxi-
mately 2kg/m
2 between 1981 and 2009 [43]. It is possible that
the increasing trend in obesity (and thus rising BMI) in the
general population may be an important factor contributing to
the rising thyroid cancer incidence. However, the inconsistent
and weak association in the studies we reviewed cannot fully
account for the large observed increases in thyroid cancer
incidence.
A common weakness of studies on BMI and thyroid cancer is
that the height and weight information used to calculate BMI is
almost always self-reported, which may lead to inaccurate or
misclassified exposure status. A systematic review comparing self-
reported height and weight to actual measurements found that
people tended to underestimate their weight and overestimate
their height leading to an underestimation of BMI [44]. Whether
this misclassification is different for each BMI category is unknown
and therefore its impact on over or underestimating risk cannot be
determined.
The association between BMI and thyroid cancer may be
confounded by multiple factors including an increased risk of
diabetes, although there has been one study showing this is not the
case [23]. Also, it is unknown whether physical activity has an
impact on thyroid cancer, with one study finding a positive
association [45] and a second finding no association [23]. Other
researchers suggest that the association between BMI and thyroid
cancer is due to detection bias because overweight and obese
people tend to see the doctor more often where they may have
examinations of the thyroid, but other research has argued against
this [25]. Based on the current evidence, it is unclear if any of these
factors can account for the weak association found between BMI
and thyroid cancer.
An increased BMI has been associated with many other tumors
in addition to thyroid cancer suggesting a general biological
mechanism between obesity and cancer [20]. The biological
processes linking high BMI to cancer risk have not yet been clearly
identified, but the potential mechanisms include insulin and
insulin-like growth factor I, sex steroids, or adipokines acting on
the thyroid to stimulate cell proliferation and suppress apoptosis
[46].
Diet
Iodine food fortification. Iodine fortification of food has
been increasing whereby 70% of the world’s population consumed
iodized salt in 2000 compared to 20% in 1990 [47]. There has
been research to suggest that chronic iodine deficiency is
associated with an increased risk of follicular carcinomas,
whereas high iodine intake is associated with increased papillary
Lifestyle and Behavioural Risks for Thyroid Cancer
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impact of iodine intake on the risk of papillary thyroid cancer is
unclear. Two case-control studies showed that papillary thyroid
cancer risk did not significantly increase with increased iodine
intake and one study showed a significant decrease in risk. It
should be noted that iodine intake categories among studies were
not comparable, which makes it difficult to discriminate between
moderate and high iodine intake. The ecological studies we
reviewed all suggested an increase in papillary cancer with
increasing iodine intake, although there are multiple
confounding factors that could account for these observations,
including other environmental risk factors, changes in histological
definitions or differences in medical practices.
There is evidence that changes in iodine intake can impact the
ratio of papillary to follicular thyroid cancers. Population studies
have found that iodine supplementation increases the proportion
of papillary thyroid cancer while iodine deficiency increases the
proportion of follicular thyroid cancer in the population exposed
to such changes [48]. It has been suggested that iodine intake
changes the ratio of papillary to follicular cancers, without actually
changing the overall incidence of thyroid cancer [49]. In our
analysis, the combination of inconsistent results from case-control
studies and methodological weaknesses among ecological studies
supports the conclusion that worldwide changes over time in
iodine intake may not be an important factor in increasing thyroid
cancer incidence rates.
Other dietary factors. It is possible that other dietary factors
may affect thyroid cancer risk. Fish and seafood are one of the
main sources of dietary iodine, and their consumption occurs at
high levels in geographic areas where the incidence of papillary
thyroid cancer is also highest, such as Iceland, Norway and
Hawaii. While the consumption of fruits and vegetables can
decrease the risk of certain types of cancer[19], cruciferous
vegetables (e.g. cabbage, Brussels sprouts, broccoli, cauliflower,
radish, turnip) are considered to be goitrogenic since they can
block iodine uptake and a large intake of them can increase
thyroid stimulating hormone (TSH).
In our analysis, the consumption of fish had no consistent
association with thyroid cancer in the studies we reviewed,
although a pooled analysis suggested a protective effect in
geographic regions with endemic goiter. The only consistent
relationship we found is that diets high in non-cruciferous raw
vegetables result in a slightly reduced risk of thyroid cancer,
suggesting a possible protective effect. On the other hand, diets
high in cruciferous vegetables were not associated with an
increased risk, as has been confirmed by animal studies which
examined the role of goitrogens on the thyroid [37]. As for other
dietary factors, the research is inconsistent in terms of the factors
studied and the magnitude of the risks identified, making it difficult
to identify specific associations. Based on studies we reviewed, diet
does not appear to be a factor that could explain the increased
thyroid cancer incidence observed worldwide.
All of the studies on diet and thyroid cancer were case-control
studies, which used retrospective interviews to determine exposure
and thus had the possibility of recall bias. Prospective cohort data
could help overcome this methodological barrier. Also, selection
bias was another major limitation as cases were often recruited
through methods that were different from the controls. In
addition, the association between thyroid cancer and diet could
not be adequately examined with respect to the impact of gender
because most studies were restricted to females only or to both
sexes combined. Lastly, it was difficult to make comparisons
between studies as they often examined different dietary
components and items, or differed in quantity and frequency of
consumption. Future studies on diet and thyroid cancer will need
to overcome these issues.
Reproductive factors
The risk of thyroid cancer in women increases at the time of
puberty and declines after menopause whereas men have a
steady increase in risk throughout their lifetime [13], providing
support to the notion that hormonal factors are involved in
some thyroid cancers. It has been hypothesized that estrogen
i n c r e a s e st h el e v e l so fT S Hi nt h eb o d y ,i nt u r ni n c r e a s i n g
thyroid growth [13]. In fact, estrogen receptors are highly
expressed in human thyroid neoplasms [13] and estrogen, along
with pregnancy and oral contraceptives use, are all associated
with elevated serum thyroxin and triiodothyronine levels, which
might induce high cell turnover[50]. The highest levels of serum
TSH, even within the normal range, are associated with a
subsequent diagnosis of thyroid cancer in individuals with
thyroid abnormalities[51]. In our review, the epidemiologic
evidence showed only weak and equivocal associations between
the major pregnancy, hormonal and menstrual cycle factors and
thyroid cancer risk.
Conclusion
Given that cancer is sometimes the result of multiple genetic,
environmental and lifestyle factors working cumulatively to
increase risk, the weak individual effect sizes identified in this
review suggest a synergistic process. For example, iodine
deficiency can promote the effects of radiation on the thyroid
gland [52]. Levels of TSH, which change as a result of exposure to
various reproductive factors and environmental chemicals, can
encourage pre-existing tumours to grow and develop into cancer
[53]. In addition to this review, we have also performed a review of
the environmental factors which may contribute to this synergistic
process (Peterson E. et al, submitted).
Future research should collect population-level exposure data
through better risk factor surveillance. More research is also
needed to explain the differences in thyroid cancer among women
and men. This could help identify and support prevention efforts
that aim to reduce the burden of thyroid cancer.
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